Description
Product Overview / 商品概要
Eril Intravenous Drip Infusion 30mg (エリル点滴静注液30mg)
Generic: Fasudil Hydrochloride Hydrate / ファスジル塩酸塩水和物
Therapeutic Category: Protein Kinase Inhibitor / 蛋白リン酸化酵素阻害剤
Manufactured by: Asahi Kasei Therapeutics Corporation / 旭化成セラピューティクス株式会社
Composition & Specification / 組成・規格
Active Ingredient: Fasudil Hydrochloride Hydrate 30.8mg (equivalent to Fasudil Hydrochloride 30.0mg) per 1 ampoule (2mL) / 1アンプル(2mL)中 ファスジル塩酸塩水和物 30.8mg(塩酸ファスジルとして30.0mg)
Additives: Isotonicity agent / 等張化剤
Appearance: Colorless clear solution
外観: 無色澄明の液
Indications / 効能効果
EN: Improvement of cerebral vasospasm and associated cerebral ischemic symptoms following subarachnoid hemorrhage surgery
JA: くも膜下出血術後の脳血管攣縮およびこれに伴う脳虚血症状の改善
Dosage and Administration / 用法用量
EN: For adults, 30mg of fasudil hydrochloride per dose is diluted in 50–100mL of electrolyte solution or glucose solution and administered by intravenous drip infusion over approximately 30 minutes, 2–3 times daily. Treatment should be initiated early after subarachnoid hemorrhage surgery and continued for 2 weeks.
JA: 通常、成人には、塩酸ファスジルとして1回30mgを50~100mLの電解質液または糖液で希釈し、1日2~3回、約30分間かけて点滴静注する。本剤の投与は、くも膜下出血術後早期に開始し、2週間投与することが望ましい。
Contraindications / 禁忌
EN: Patients with active bleeding (intracranial hemorrhage); patients at risk of intracranial hemorrhage (patients in whom adequate intraoperative hemostasis of a ruptured aneurysm could not be achieved); patients with hypotension
JA: 出血している患者(頭蓋内出血)、頭蓋内出血の可能性のある患者(出血した動脈瘤に対する十分な止血処置を術中に施すことができなかった患者)、低血圧の患者
Regulatory Information / 規制情報
Approval No.: 21900AMX00715000
Sales Started: August 1995 / 1995年8月
Classification Code: 87219
Storage: Store at room temperature / 室温保存
Shelf Life: 36 months / 36ヵ月
Packaging / 包装
Main Package (for sale): 2mL x 10 ampoules / 2mL×10アンプル
Other Available Packages (by special order): 2mL x 10 ampoules
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.




Reviews
There are no reviews yet.